Sequence 9 from Patent US 20120302729
General Information
DCTPep ID DCTPep01409
Peptide Name Sequence 9 from Patent US 20120302729
Sequence DLFGR
Sequence Length 5
UniProt ID A0A2L0P0K3 P51592 O95071 Q80TP3 Q62671 Q9VXG8 O60503 P51830 Q9DGG6 Q9I0F4 Q9VW60 P98999 Q7UDY6 A2A870 Q3ZBA0 Q80VP0 Q7Z6L1 Q5R5Y0 P10857 P28962 Q9HCM7 P40469 D5GI81 Q9DUT3 B2W0
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula Not Applicable
Absent amino acids Not Applicable
Theoretical pI Not Applicable
Acidic residues Not Applicable
Basic residues Not Applicable
Polar residues Not Applicable
Molecular weight (Average) Not Applicable
Molecular weight (Monoisotopic) Not Applicable
Common amino acids Not Applicable
Net charge Not Applicable
Instability index (II) Not Applicable
Aliphatic index Not Applicable
Grand average of hydropathicity (GRAVY) Not Applicable
Half Life
Not Applicable
Extinction coefficients
Not Applicable
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4